Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered
Human content, AI powered search.

Latest Stories

Search

Human content, AI powered search.

Search Results for asthma

Health minister visits St Mary’s Hospital to launch NRP
News

Health minister visits St Mary’s Hospital to launch NRP

Dr Zubir Ahmed visited Imperial Clinical Respiratory Research Unit to see cutting-edge asthma and COPD care in action

£10 million partnership to bring asthma, COPD care closer home
Respiratory & Lung Health

£10 million partnership to bring asthma, COPD care closer home

New Respiratory Transformation Partnership (RTP) aims to move care from hospital wards to local communities

NICE recommends digital tools for asthma control
News

NICE recommends digital tools for asthma control

The tools ensure personalised asthma care for the users

NICE backs eight digital asthma management platforms
News

NICE backs eight digital asthma management platforms

NICE has provided draft guidance to these platforms, and it will be collecting further evidence over the next three years

MHRA approves depemokimab asthma treatment
News

Biological medicine jab approved for asthma and chronic rhinosinusitis

This is the first ever six-monthly add-on medication for these health conditions

Wales allows patients needing time-sensitive surgery to access weight loss jabs
Obesity & Weight Management

Wales allows patients needing time-sensitive surgery to access weight loss jabs

The government will ensure that tirzepatide and other weight loss medications are more widely available

Pfizer RSV vaccine MHRA Abrysvo adults 18-59 UK NHS update news
Respiratory & Lung Health

Pfizer’s RSV vaccine to cover at-risk adults aged 18 to 59: MHRA

Abrysvo has become the only licenced vaccine in the UK for patients with higher risk of lower respiratory tract disease (LRTD) caused by RSV

AstraZeneca
Respiratory & Lung Health

AstraZeneca's asthma drug fails 'smoker's lung' study

Fasenra is AstraZeneca's second-best selling drug from its respiratory and immunology portfolio